Skip to main content

What is the difference between Ixifi and Remicade?

Medically reviewed by Last updated on Sep 7, 2023.

Official answer


Ixifi (infliximab-qbtx) is a tumor necrosis factor (TNF) blocker that is biosimilar to Remicade (infliximab).

Biosimilars are approved through an abbreviated licensure pathway for biological products that are shown to be interchangeable with an already FDA-approved biological product.

What Are Biosimilars? Top Facts You May Not Know

Ixifi and Remicade are used for the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.

Ixifi is not interchangeable with Remicade at the pharmacy level unless specifically noted by the prescribing doctor.

For more information, see Comparing Ixifi vs Remicade

Related medical questions

Drug information

Related support groups